MR perfusion imaging, along with intracoronary pressure data, may help identify hemodynamically relevant coronary artery diseases, according to a study presented this week at the North American Society for Cardiac Imaging meeting in Amelia Island, FL.
MR perfusion imaging, along with intracoronary pressure data, may help identify hemodynamically relevant coronary artery diseases, according to a study presented this week at the North American Society for Cardiac Imaging meeting in Amelia Island, FL.
Dr. Armin M. Huber and colleagues from the Klinikum Grosshadern and Klinikum Innenstadt in Munich found that semiquantitative MR perfusion parameters with results from intracoronary pressure-derived fractional flow reserve correctly assessed the hemodynamic relevance of known coronary artery lesions.
Twenty-one patients underwent coronary MR angiography with intracoronary pressure wire examination for determination of fractional flow reserve in 23 stenotic lesions. SI curves of the first-pass MR perfusion imaging (SR-turboFLASH) of the myocardium were analyzed at rest and under adenosine-induced hyperemia.
Researchers determined time-to-peak, maximum signal intensity, and upslope values using a 16-segment model. They divided lesions into three groups:
A total of 336 perfusion areas were evaluated. Time-to-peak and upslope at rest values were not significantly different among the three groups. Stress upslope measurements of normal coronary arteries and severe coronary stenoses, however, were significantly different.
The ratio for upslope at stress and rest was 3.4 (2.0-6.3) for normal coronary arteries and 1.7 (1.2-1.7) and 1.1 (1.0-1.3) for intermediate and severe coronary lesions (p
Time-to-peak and upslope at rest measurements were not able to discriminate between normal and severely stenosed coronary arteries, Huber said. Measurements for upslope under stress and the ratio between upslope under stress and upslope at rest were significantly different between normal and significantly functionally diseased coronary arteries.
"The use of these MRI parameters may therefore improve the sensitivity and specificity of noninvasive identification of hemodynamically relevant CAD," he said.
FDA Clears Virtually Helium-Free 1.5T MRI System from Siemens Healthineers
June 26th 2025Offering a cost- and resource-saving DryCool magnet technology, the Magnetom Flow.Ace MRI system reportedly requires 0.7 liters of liquid helium for cooling over the lifetime of the device in contrast to over 1,000 liters commonly utilized with conventional MRI platforms.
Multinational Study Reaffirms Value of Adjunctive AI for Prostate MRI
June 16th 2025The use of adjunctive AI in biparametric prostate MRI exams led to 3.3 percent and 3.4 percent increases in the AUC and specificity, respectively, for clinically significant prostate cancer (csPCa) in a 360-person cohort drawn from 53 facilities.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.